Dr Reddy's Laboratories appoints Penny Wan as an Additional Director

28 Jan 2022 , 02:03 PM

Dr. Reddy’s Laboratories Ltd has announced the appointment of Penny Wan as an Additional Director, categorized as Independent, on the Board of the company, for a term of five consecutive years, effective January 28, 2022.

Penny Wan was most recently Amgen’s Vice President of Japan and the Asia Pacific region. With over 20 years of experience in the biopharmaceuticals industry, she led Amgen’s geographic expansion efforts in the region. Since joining the Company in 2014, she has been instrumental in building Amgen’s commercial presence across the region, ensuring that innovative medicines reach patients, payers, and physicians in these markets.

Penny brings deep experience across healthcare. She has comprehensive management experience and strategic skills in leading sales and marketing, manufacturing, business development, start-up, country, and regional operations in global markets, including China and Japan in world-class pharma and healthcare companies.

Dr Reddys Laboratories is currently trading at Rs4,254 down by Rs2.45 or 0.06% from its previous closing of Rs4,256.45 on the BSE.